Investing In Tuniu Corporation (NASDAQ: TOUR) Does Not Require High Risk Tolerance

view original post

During the last session, Tuniu Corporation (NASDAQ:TOUR)’s traded shares were 0.47 million, with the beta value of the company hitting 1.48. At the end of the trading day, the stock’s price was $1.11, reflecting an intraday loss of -0.89% or -$0.01. The 52-week high for the TOUR share is $2.14, that puts it down -92.79 from that peak though still a striking 58.56% gain since the share price plummeted to a 52-week low of $0.46. The company’s market capitalization is $144.02M, and the average trade volume was 2.45 million shares over the past three months.

Tuniu Corporation (TOUR) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 3.00. TOUR has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Tuniu Corporation (TOUR) registered a -0.89% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.89% in intraday trading to $1.11 this Friday, 07/15/22, hitting a weekly high. The stock’s 5-day price performance is -13.28%, and it has moved by 114.95% in 30 days. Based on these gigs, the overall price performance for the year is -47.64%.

The consensus price target of analysts on Wall Street is $7.06, which implies an increase of 84.28% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7.06 and $7.06 respectively. As a result, TOUR is trading at a discount of -536.04% off the target high and -536.04% off the low.

Tuniu Corporation (TOUR) estimates and forecasts

In the rating firms’ projections, revenue will decrease -46.70% compared to the previous financial year.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 44.90%. While earnings are projected to return 90.70% in 2022, the next five years will return -0.01% per annum.

TOUR Dividends

Tuniu Corporation is due to release its next quarterly earnings between March 14 and March 18. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Tuniu Corporation (NASDAQ:TOUR)’s Major holders

Tuniu Corporation insiders own 1.68% of total outstanding shares while institutional holders control 29.69%, with the float percentage being 30.20%. Morgan Stanley is the largest shareholder of the company, while 19 institutions own stock in it. As of Dec 30, 2021, the company held over 4.51 million shares (or 3.84% of all shares), a total value of $4.38 million in shares.

The next largest institutional holding, with 4.51 million shares, is of Morgan Stanley’s that is approximately 3.83% of outstanding shares. At the market price on Dec 30, 2021, these shares were valued at $4.38 million.

Also, the Mutual Funds coming in first place with the largest holdings of Tuniu Corporation (TOUR) shares are DFA Emerging Markets Small Cap Series and DFA Emerging Markets Core Equity Portfolio. Data provided on Jan 30, 2022 indicates that DFA Emerging Markets Small Cap Series owns about 0.15 million shares. This amounts to just over 0.13 percent of the company’s overall shares, with a $0.2 million market value. The same data shows that the other fund manager holds slightly less at 88047.0, or about 0.07% of the stock, which is worth about $0.12 million.